Motor neurone disease impacts nerves located in the brain and spinal cord, that instruct your muscles what to do.
This causes them to weaken and become rigid over time and usually affects how you walk, speak, consume food and respire.
It is a quite uncommon condition that is most frequent in individuals over 50, but adults of any age can be affected.
A person's lifetime risk of developing MND is 1 out of 300.
About five thousand people in the UK will have the condition at any given moment.
Scientists are uncertain the cause of MND, but it is likely to be a mix of the genetic material - or inherited characteristics - you inherit from your mother and father when you are born, and other environmental influences.
In as many as 10% of people with MND, particular genetic factors are far more significant.
There is usually a family history of the illness in such instances.
MND affects everyone differently.
Not all individuals has the identical signs, or experiences them in the identical sequence.
The disease can advance at varying rates too.
Among the most common signs are:
No cure, but there is optimism stemming from therapies focused on different forms of MND.
MND is not a single illness - it is actually multiple that culminate in the demise of motor neurones.
An innovative medication known as tofersen works in just 2% of patients, however it has been demonstrated to slow - and in some cases even undo - a portion of the symptoms of MND.
It has been described as "absolutely groundbreaking" and a "significant point of optimism" for the entire condition.
Even though the drug has recently been approved in the European Union, it is not yet available in the UK.
Just one drug presently approved for the management of MND in the UK and endorsed by the NHS.
Riluzole could decelerate the advancement of the disease and prolong life by several months, but it cannot repair damage.
Certain individuals can survive for decades with MND, including theoretical physicist Stephen Hawking, who was diagnosed at the twenty-two years old and lived to 76.
But for the majority, the disease progresses quickly and life expectancy is just a few years.
According to the charity MND Association, the condition claims the lives of a one-third of individuals within a twelve months and more than half within 24 months of identification.
As the nerve cells cease functioning, ingestion and breathing become more challenging and numerous individuals need feeding tubes or breathing apparatus to help them remain living.
The exact cause has not been identified, but elite athletes appear overrepresented by MND.
A pair of research projects from 2005 and 2009 indicated that soccer players have an increased risk of contracting MND.
Research from 2022 by the University of Glasgow involving 400 former Scotland rugby athletes concluded they had an increased risk of acquiring the condition.
Scientists also found that rugby players who have experienced repeated head injuries have biological differences that could render them more susceptible to developing MND.
The MND Association acknowledges there is a "correlation" between contact sports and MND.
It added that while the sportspeople researched were had a greater chance to acquire MND, it did not show the sports directly led to the disease.
The organization also stresses that "documented MND instances in these studies is remains quite small, and so concluding there is a certain elevated chance could be misunderstood if this is merely a cluster due to random chance".
Several high-profile sports figures have been identified with the disease in the past few years.
These include ex- rugby union players, footballers, and cricket athletes.
Across the Atlantic, MLB athlete Lou Gehrig died from the condition aged 39.
A registered nurse and entrepreneur passionate about improving patient care through innovative design and business solutions.